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ABSTRACT 50 
We report a novel host-associated virulence plasmid in Rhodococcus equi, pVAPN, carried by 51 
bovine isolates of this facultative intracellular pathogenic actinomycete. Surprisingly, pVAPN 52 
is a 120-kb invertron-like linear replicon unrelated to the circular virulence plasmid associated 53 
with equine (pVAPA) and porcine (pVAPB variant) R. equi isolates. pVAPN is similar to the 54 
linear plasmid pNSL1 from Rhodococcus sp. NS1 and harbors six new vap multigene family 55 
members (vapN to -S) in a vap pathogenicity locus acquired via en-bloc mobilization from a 56 
direct predecessor of the equine pVAPA. Loss of pVAPN rendered R. equi avirulent in 57 
macrophages and mice. Mating experiments using an in vivo transconjugant selection strategy 58 
demonstrated that pVAPN transfer is sufficient to confer virulence to a plasmid-cured R. equi 59 
recipient. Phylogenetic analyses distributed the vap multigene family complement from 60 
pVAPN, pVAPA and pVAPB in seven monophyletic clades, each containing plasmid type-61 
specific allelic variants of a precursor vap gene carried by the nearest vap island ancestor. 62 
Deletion of vapN, the predicted “bovine-type” allelic counterpart of vapA essential for 63 
virulence in pVAPA, abrogated pVAPN-mediated intramacrophage proliferation and 64 
virulence in mice. Our findings support a model in which R. equi virulence is conferred by 65 
host-adapted plasmids. Their central role is mediating intracellular proliferation in 66 
macrophages, promoted by a key vap determinant present in the common ancestor of the 67 
plasmid-specific vap islands, with host tropism as a secondary trait selected during co-68 
evolution of individual virulence plasmids with specific animal species.  69 
70 
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Rhodococcus equi is a gram-positive aerobic coccobacillus of the Actinomycetales associated 71 
with chronic or subacute pyogenic infections (1, 2). A normal soil inhabitant, the bacterium 72 
uses manure as a growth substrate, multiplies in the herbivore’s large intestine and is 73 
ubiquitous in the farm environment. Transmission occurs via contaminated dust particles, 74 
mostly through airborne exposure (3, 4). R. equi is the causative agent of a major infectious 75 
disease of the horse that affects young foals worldwide. The infection is characterized by 76 
multifocal purulent bronchopneumonia, often accompanied by ulcerative or abcessating 77 
lesions in the intestine (1, 5). While most well known as an equine pathogen, R. equi also 78 
infects other animal species (1, 6-8). In abattoir surveys, R. equi is frequently recovered from 79 
porcine submaxillary lymph nodes with granulomatous lesions as well as from apparently 80 
healthy pigs (9-11). In cattle, it is typically isolated from caseating abscesses in respiratory 81 
lymph nodes resembling bovine tuberculosis (TB) lesions (12). R. equi is also recognized as 82 
an opportunistic pathogen in humans, where it causes severe TB-like purulent cavitary 83 
pneumonia, bacteremia and extrapulmonary localized infections (8, 13, 14). 84 
 R. equi pathogenesis depends on the capacity of the bacterium to survive and replicate 85 
within host macrophages (15-18). In equine isolates, this ability is conferred by a conjugative 86 
circular plasmid of 80 kb (19-21) that promotes intravacuolar survival by interfering with 87 
phagosome maturation (22). These properties are mediated by the vap pathogenicity island 88 
(PAI) (23), a horizontal gene transfer (HGT) locus (24). A hallmark of the vap PAI is the 89 
presence of a multigene family encoding homologous virulence-associated proteins (Vap) 90 
(20, 24, 25). One of them, VapA, a 19 kDa secreted protein, is essential for virulence. A 91 
single vapA gene deletion causes strong attenuation comparable to that caused by loss of the 92 
plasmid, with both an inability to proliferate in macrophages and to survive in vivo in mice 93 
(26, 27).  94 
 Emerging evidence suggests that the virulence plasmid may also play a key role in R. 95 
equi host tropism. Early studies showed that VapA-encoding virulence plasmids were typical 96 
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of equine strains (28, 29), while a second plasmid type encoding VapB, a VapA variant (24), 97 
was common among non-equine (pig and human) isolates (10, 30-33). Recently, the existence 98 
of a third type of R. equi virulence plasmid was identified in bovine and human isolates 99 
initially deemed to be “plasmidless” because negative for the vapA and vapB gene markers, 100 
but which tested positive for a traA plasmid conjugal transfer gene marker (34). Molecular 101 
epidemiological analysis of a global collection of R. equi isolates established that the vapA+, 102 
vapB+ and novel vapAB– plasmid types were each associated with a specific non-human host, 103 
i.e. equine, porcine and bovine, respectively (34). Using a unified nomenclature these 104 
plasmids were designated, respectively, pVAPA, pVAPB and pVAPN (for “noA-noB” 105 
virulence plasmid) (1, 24). In contrast to their unique animal species specificity, the three 106 
host-adapted plasmid types were commonly detected in human isolates. Besides pointing to a 107 
zoonotic origin of the infection, this lack of plasmid type selectivity was consistent with 108 
humans being an opportunistic, non-adapted host for R. equi (34).  109 
 Sequencing of the pVAPA and pVAPB virulence plasmids revealed they are 110 
essentially the same circular replicon (24). The analyzed plasmids, pVAPA1037 and 111 
pVAPB1593 (numerical suffix indicating the source strain according to recently suggested 112 
harmonized nomenclature for R. equi virulence plasmids) (24), shared a virtually identical 113 
backbone encoding replication/partitioning and conjugal transfer functions. In contrast, the 114 
vap PAI was more divergent, differing both in size and vap gene complement, i.e. ≈21 kb and 115 
nine vap genes for pVAPA (vapA, -C, -D, -E, -G and -H and the pseudogenes vapF, -I and -X) 116 
vs ≈15 kb and six vap genes for pVAPB (vapB, -J, -K1, -K2, -L and -M) (24). In addition to 117 
major Vap polypeptide sequence diversification, vap multigene family re-arrangements 118 
(duplications and translocations) and insertion/deletions affecting adjacent genes accounted 119 
for the PAI differences. This suggested that the vap PAIs were evolving at a faster rate than 120 
the conserved housekeeping backbone, consistent with diversifying selection and a possible 121 
role in host-specific adaptation (24).  122 
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 Here, we report the genomic analysis and characterization of pVAPN, the bovine-type 123 
R. equi virulence plasmid.  124 
 125 
MATERIALS AND METHODS 126 
Strains, culture conditions and reagents. R. equi PAM1571 is a prototypic traA+/vapAB– 127 
bovine strain (34) isolated from a heifer’s mediastinal lymph node with pyogranulomatous 128 
lesions (kindly provided by F. Quigley, Central Veterinary Research Laboratory, Ireland) 129 
(12). Its plasmid-cured derivative PAM1571– was obtained by subjecting the wild-type 130 
bacteria to an electroporation pulse of 12.5 kV/cm, 1000 Ω and 25 μF (GenePulser Xcell, 131 
BioRad) followed by six cycles of plating and single-colony subculturing in liquid medium at 132 
37 ºC (27). These two strains are henceforth designated 1571 and 1571–, respectively. R. equi 133 
PAM2012 is another traA+/vapAB– bovine strain, isolated in Germany from a case of 134 
lymphadenitis in cattle (kindly provided by C. Lämmler, Veterinary Faculty, University of 135 
Giessen) (35). R. equi 103S is the reference genome strain, a low passage clone of equine 136 
clinical isolate 103+ used in different laboratories worldwide (24). Its isogenic 103SΔvapA 137 
and plasmid-cured 103S– derivatives have been described elsewhere (27). The presence of the 138 
virulence plasmid was routinely checked in all strains by PCR using suitable oligonucleotide 139 
primer combinations (Table S1). R. equi was grown in brain-heart infusion (BHI, Difco-BD) 140 
or Luria-Bertani (LB, Sigma) media at 30 ºC unless stated otherwise. The cloning host strain 141 
Escherichia coli DH5α was grown at 37 ºC in LB. Media were supplemented with 1.5% agar 142 
(w/v) and/or antibiotics as appropriate. Fluid cultures were incubated with shaking (200 rpm). 143 
Chemicals and primers were purchased from Sigma-Aldrich unless stated otherwise.  144 
 DNA techniques. Total DNA extraction and purification from R. equi, PCR 145 
techniques, DNA fragment purification and electrophoresis, recombinant DNA techniques, 146 
and plasmid purification and electroporation, were performed as previously described (27, 34, 147 
36). For pulsed-field DNA electrophoresis (PFGE), plugs were formed by embedding R. equi 148 
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cells from 1-ml 24-h BHI culture aliquots in melted 1% agarose in TE buffer. Plugs were 149 
incubated in lysozyme solution (10 mM Tris-HCl pH 8.0, 50 mM NaCl, 1 mg/ml lysozyme) 150 
at 37°C for 2 h, washed in 20 mM Tris-HCl pH 8.0, 50 mM EDTA and incubated in 151 
proteinase K solution (10 mM TrisHCl pH 8.0, 100 mM EDTA, 0.2 g/ml sucrose, 1 mg/ml 152 
proteinase K) at 50 °C overnight. Plugs were then loaded into 1% Pulsed Field CertifiedTM 153 
agarose gel (BioRad) prepared with 0.5× Tris-borate-EDTA buffer (TBE). DNA was 154 
separated in a CHEF-DR(R) II Pulsed Field Electrophoresis System (BioRad) at 5 V/cm2 155 
voltage, switch time ramping from 20 to 30 s, and 23 h run time at 14°C. Southern blotting 156 
was performed by transferring resolved DNA fragments to a positively-charged nylon 157 
membrane after treatment of the PFGE gels with 0.25 M HCl for 30 min followed by 158 
denaturing solution (1.5 M NaCl, 0.4 M NaOH) for 20 min (twice) and neutralizing solution 159 
(1.5 M NaCl, 0.5 M TrisCl2 pH 7.0) for 20 min (twice). Membranes were hybridized using a 160 
specific vapN-vapQ PCR fragment (Table S1) labelled with digoxigenin (DIG High Prime 161 
DNA Labeling and Detection Kit, Roche). 162 
  pVAPN sequencing and phylogenetic analyses. pVAPN1571 was electroeluted from 163 
preparative PFGE gels using a Model 422 apparatus and (BioRad) and pair-end (2× 36-bp) 164 
sequenced in an Illumina (Solexa) II Genome Analyzer at Edinburgh Genomics facility. To 165 
complete the plasmid assembly, the host strain 1571 was paired-end (2× 100-bp) sequenced 166 
from a 500 bp PCR-free library using an Illumina HiSeq 2000 Sequencing System at Beijing 167 
Genomics Institute. pVAPN2012 was entirely sequenced using the latter approach. Reads 168 
were assessed for quality using FASTQC, then trimmed for adaptors using SCYTHE and for low 169 
quality reads using SICKLE. De novo assembly was performed using SPADES followed by 170 
manual verification by PCR mapping and Sanger re-sequencing of specific regions. The 5’ 171 
end telomeric sequence of pVAPN was experimentally confirmed as previously described 172 
(37) using the suicide vector pSelAct (38) and the vector-encoded apramycin resistance for 173 
selecting positive clones. The pVAPN sequence was manually curated and annotated in 174 
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ARTEMIS using the software and databases listed in Table S2. For phylogenetic analyses, 175 
orthologs were identified by reciprocal TBLASTX analysis with 30% identity over >60% of the 176 
protein sequence as minimum similarity score. Paralogous genes predicted based on the 177 
topology of Neighbor joining trees and pseudogenes (except vap pseudogenes) were avoided. 178 
Translated products from each ortholog cluster were MUSCLE-aligned (except otherwise 179 
stated) and back-translated in MEGA5, and best evolutionary model for nucleotide substitution 180 
was selected according to AIC criterion in JMODELTEST. For Multilocus Sequence Alignment 181 
(MLSA), gene alignments were concatenated with SEAVIEW. Maximum Likelihood (ML) 182 
trees were constructed in PHYML. See Table S2 for bioinformatics and phylogenetic analysis 183 
software references/urls.  184 
  Construction of vapN deletion mutant. The vapN gene was in-frame deleted from 185 
pVAPN by double homologous recombination (36) using 5-fluorocytosine counter-selection 186 
(38). Briefly, oligonucleotide primer pairs Nmutant_a (EcoRI))/Nmutant_b1 (XmaI) and 187 
Nmutant_c1 (XmaI)/Nmutant_d (SpeI) (Table S1) were used to PCR-amplify two DNA 188 
fragments of 908 and 910 bp carrying the last three 5’-terminal and four 3’-terminal codons of 189 
vapN plus adjacent upstream and downstream regions, respectively. The PCR products were 190 
joined via the XmaI site introduced by the Nmutant_b1 and Nmutant_c1 primers, the ligation 191 
product inserted into the pSelAct vector (38) using the external SpeI and EcoRI sites 192 
introduced by the primers Nmutant_a and Nmutant_d, and the resulting plasmid 193 
electroporated into 1571. Allele exchange was monitored by PCR mapping using suitable 194 
primers (Table S1) and the in-frame deletion confirmed by DNA sequencing on both strands.  195 
  Mating experiments. Transfer of the virulence plasmid between R. equi bacteria was 196 
investigated using a mating protocol essentially as previously described (39). Overnight BHI 197 
cultures of donor and recipient R. equi were harvested by centrifugation, resuspended in 198 
phosphate-buffered saline (PBS) to a cell density of ≈107 CFU, mixed ≈1:1 and spotted in a 199 
≈5 μl drop onto BHI agar. The recipient 103S– bacteria carried a chromosomal rifampicin 200 
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resistance (RmpR) marker. 103S–RmpR bacteria were isolated by selection of spontaneous 201 
resistant mutants on increasing concentrations of rifampicin, from 25 to 100 µg/ml, and 202 
stabilization by repeated subculturing in the presence of the highest concentration of the 203 
antibiotic. After incubating the mating mixture at 30 ºC for 72 h, bacteria were collected in 1 204 
ml of PBS, serially diluted, and plated onto BHI agar without and with supplementation with 205 
100 µg/ml rifampicin. At this rifampicin concentration, no RmpR colonies were detected in 206 
the only-donor control plates. Transconjugants were identified among RmpR colonies by 207 
simultaneous PCR detection of virulence plasmid-specific markers and of recipient’s 208 
chromosomal gene markers (103S strain-specific sequences identified from genome 209 
comparisons) using ad hoc oligonucleotide primers (Table S1).  210 
 Macrophage cultures and infection assay. Low-passage murine J774A.1 211 
macrophages and human monocyte-like THP-1 cells were obtained from ATCC and cultured 212 
at 37 °C under 5 % CO2 in Dulbecco’s minimal essential medium supplemented with 10% de-213 
complemented fetal bovine serum, 2 mM glutamine and 1 mM pyruvate (DMEM). THP-1 214 
cells were initially grown in suspension in RPMI-1640 medium with the same supplements. 215 
Cells were seeded on 24-well plates at a density of ≈2×105 cells/well and incubated overnight 216 
in DMEM, for THP-1 monocytes in the presence of 50 ng/ml phorbol 12-myristate 13-acetate 217 
(PMA) to allow differentiation into macrophages. Infection assays were performed on ≈80% 218 
confluent macrophage monolayers as previously described (40). Intracellular proliferation 219 
data were normalized to the initial counts at t = 0 using an “Intracellular Growth Coefficient” 220 
according to the formula: IGC = (IBn – IB0) / IB0, where IBn and IB0 are the intracellular 221 
bacterial numbers at t= n and t= 0, respectively (40, 41).  222 
  Mouse infections. Experiments were performed at the Animal Facility of the School 223 
of Biological Sciences of the University of Edinburgh using in-house-bred six- to eight-week-224 
old BALB/c mice. Mouse intranasal and intravenous infections and the lung competitive 225 
virulence assay were performed as previously described (27). The relative proportion of the 226 
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competing bacteria was calculated by analyzing at least 40 random colonies from the plated 227 
organ homogenate by PCR using suitable oligonucleotide primers (Table S1). Competitive 228 
index values were calculated using the formula C.I. = (test/reference log CFU ratio at t = n) / 229 
(input test/reference log CFU ratio in inoculum) (27). Mouse experiments were approved by 230 
the University of Edinburgh’s Ethical Review Committee and were covered by a Project 231 
License granted by the UK Home Office under the Animals (Scientific Procedures) Act 1986. 232 
  Statistics. Intracellular proliferation and uptake data were compared using two-way 233 
and one-way ANOVA, respectively, followed by Šidák post-hoc multiple comparison tests. 234 
One-sample Student’s t tests were used to determine if C.I. values differed significantly from 235 
1 (i.e. the expected C.I. value if the ratio of the competing strains remains the same respect to 236 
t = 0). Statistical analyses were performed using Prism 6.0 software (GraphPad, San Diego, 237 
CA).  238 
 239 
RESULTS AND DISCUSSION 240 
Identification and sequencing of pVAPN. Attempts to isolate the novel traA+/vapAB– 241 
plasmid type (34) from 1571 and other bovine isolates using the procedure for R. equi circular 242 
virulence plasmid extraction (34) were unsuccessful. However, PFGE analysis of undigested 243 
genomic DNA revealed a distinct band in the range of ≈100 Kb in all bovine strains from our 244 
collection (n = 22). This band was not detected in R. equi strains carrying a circular virulence 245 
plasmid e.g. 103S harboring pVAPA (Fig. 1). Similarity searches of exploratory low-246 
coverage whole-genome 454 pyrosequencing assemblies from 1571 with the pVAPA 247 
reference sequence from R. equi 103S (40) identified contigs harboring vap PAI-homologous 248 
genes. Southern blotting using a probe from this novel vap PAI identified the ≈100 Kb PFGE 249 
band as the putative pVAPN virulence plasmid (Fig. 1). Most (95%) tested traA+/vapAB– 250 
bovine isolates (34) were positive for pVAPN by PCR using a plasmid-specific vap PAI 251 
marker (vapN, the counterpart of the equine vapA and porcine vapB, see below). The ≈100-252 
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Kb band from strain 1571 was isolated from PFGE gels and shotgun sequenced. The 253 
pVAPN1571 genome sequence was completed as described in Materials & Methods.  254 
 pVAPN1571 is 119,931 bp long and contains 148 open reading frames (ORFs), of 255 
which 10 are pseudogenes (Fig. 2). The average G+C content is 66.2 %, similar to that of R. 256 
equi genomic DNA (68.7%) (40). pVAPN1571 is predicted to be a linear replicon based on 257 
its PFGE migration pattern (42), presence of a traB conjugal translocase determinant (see 258 
below), phylogenetic relatedness with other Rhodococcus linear plasmids (Fig. 3A), and 259 
presence of telomeric invertron-like terminal inverted repeats (TIR) with multiple palindromic 260 
secondary structures (Fig. 4) (43-45). pVAPN’s TIR sequences are 569 bp-long and 99% 261 
identical. The nucleotide sequence of a second example of pVAPN plasmid, from a bovine 262 
isolate from Germany (PAM2012), was virtually identical to that of pVAPN except for the 263 
presence of two additional ORFs before the left telomeric sequence (Fig. S1). The 264 
pVAPN1571 and pVAPN2012 genome sequences have been deposited in GenBank under 265 
Accession Nos. KF439868 and KP851975, respectively  266 
 Comparative analysis and functional overview. Rhodococcus species 267 
characteristically possess large plasmids, circular or linear if >100 Kb in size (46). They 268 
consist of a vertically evolving backbone, encoding plasmid maintenance and conjugal 269 
transfer functions, and a horizontally acquired variable region (VR) providing specific niche-270 
adaptive properties to the host bacterium (24, 37, 44, 45, 47). The housekeeping backbone of 271 
pVAPN is unrelated to that of the circular pVAPA/B (equine/porcine type) R. equi virulence 272 
plasmids. pVAPN instead is closely related to the linear plasmid pNSL1 from Rhodococcus 273 
sp. NS1 (48) in terms of genetic structure and synteny (Fig. 2). pNSL1 is of a similar size 274 
(117, 252 bp) and perfectly colinear with pVAPN. No significant overall similarity was 275 
detected with other sequenced linear plasmids from the genus Rhodococcus in pairwise 276 
alignments (Fig. S3). However, a phylogenetic multilocus sequence analysis (MLSA) of gene 277 
orthologs from the housekeeping backbones of a representation of rhodococcal linear and 278 
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circular plasmids placed pVAPN within a monophyletic clade together with the linear 279 
replicons, indicating they all share a common origin (Fig. 3A).  280 
 Conjugation genes. pVAPN encodes a MOBf (TrwC)-family conjugal relaxase (49) 281 
homologous to TraA from pVAPA/B (24). Detection of its coding sequence (pVAPN_0650) 282 
by PCR using conserved traA target sequences from pVAPA/B allowed the discovery of the 283 
traA+/vapAB– bovine pVAPN plasmid in a first instance (34). Relaxases play a key role in the 284 
conjugation of circular plasmids, nicking the supercoiled dsDNA and leading the nascent 285 
DNA strand into the recipient cell in conjunction with a type IV secretion system (T4SS), 286 
which forms the transport channel (50, 51). Indeed, deletion of traA has been shown to 287 
prevent the transfer of the equine pVAPA circular virulence plasmid (39). Interestingly, 288 
however, the pVAPN traA relaxase gene is corrupted (5’ terminal deletion affecting the first 289 
75 codons including gene start and part of TrwC relaxase domain, frameshifts in the 3’ 290 
terminal region) and probably non-functional. This traA pseudogene is located outside the 291 
pVAPN conjugation module at the left boundary of the vap PAI. It is immediately contiguous 292 
to three ORFs encoding phage excisionase, Rep and CopG (regulator of plasmid copy 293 
number) homologs, also present in the pVAPA/B backbone (24). These three ORFs and 294 
adjacent pVAPN vap PAI are identified as HGT by the ALIEN_HUNTER program, which 295 
detects putative horizontally acquired genetic material based on local compositional bias (52) 296 
(Fig. 2). This suggests that the traA pseudogene-phage excisionase-rep-copG genes (absent 297 
from pNSL1) are remnants of a lateral gene exchange –probably the same that mobilized the 298 
vap PAI locus– between the circular virulence plasmid and pVAPN.  299 
 Despite traA being a pseudogene and a relaxase-associated T4SS apparatus being 300 
absent, pVAPN is transferable by mating (see below). This is probably mediated by 301 
pVAPN_0320 encoding a TraB plasmid translocase, also present in pNSL1. TraB 302 
translocases are evolutionarily related to the septal FtsK/SpoIIE-family proteins involved in 303 
chromosome segregation (51) and have been recently shown to mediate a novel relaxase-304 
 12
/T4SS-independent mechanism of conjugation in Streptomyces linear replicons (53). They all 305 
share a similar structural arrangement, with an AAA+ motor ATPase domain with 306 
characteristic Walker A and B boxes, a transmembrane domain and a C-terminal DNA-307 
binding winged helix-turn-helix motif (53). In translocase-mediated conjugation, TraB binds 308 
to the plasmid’s dsDNA and forms a transmembrane DNA-conducting hexameric channel 309 
through which the plasmid is transferred to the recipent bacterium in an ATP-dependent 310 
manner. The pVAPN (and pNSL1) conjugation module also comprises (i) an additional 311 
AAA+ ATPase with sequence similarity to the conjugative coupling factor TraD 312 
(pVAPN_0360); (ii) a homolog of a Soj/ParA-family ATPase (pVAPN_0300), involved in 313 
chromosomal and plasmid DNA segregation (54) and recruitment of conjugative DNA to the 314 
transfer channel (55); (iii) a putative M23 endopeptidase family/lysozyme-like lytic murein 315 
transglycosylase/cell wall hydrolase (pVAPN_0390), probably involved in conjugation 316 
channel formation (of which a homolog is also present in the circular pVAPA/B virulence 317 
plasmids and related R. erythropolis pREC1) (Fig. 2); and (iv) a number of putative 318 
membrane-associated proteins. In addition, pVAPN_0550, at the other side of an interposed 319 
plasmid replication/partitioning (rep-parA) module, encodes a putative cutinase. A cutinase 320 
gene is also present at the boundary of this replication/partitioning module and the 321 
conjugation module in the circular pVAPA/B and pREC1 replicons (Fig. 2). Bacterial 322 
cutinase-like proteins, common among mycolic-acid containing actinomycetes (40, 56), have 323 
esterase/lypolytic activity (56-58). In mycolata-infecting phages they form part of the LysB 324 
lipolytic enzyme complement, thought to aid in the breakdown of the lipid-rich envelope 325 
during phage penetration or lytic egress (59). Recently, a cutinase from R. fascians pFiD188 326 
linear virulence plasmid has been shown to be required for efficient conjugation, probably by 327 
facilitating the penetration of the DNA translocation complex in the rhodococcal cell 328 
envelope (45).   329 
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 Replication/partitioning. The pVAPN self-replication determinant includes a module 330 
encoding a Rep protein (pVAPN_0480), which probably directs the bidirectional replication 331 
of the plasmid towards the telomeres, and the plasmid partitioning protein/ATPase ParA 332 
(pVAPN_0500). A 26-bp semi-palindromic sequence (5’-333 
AAAACCCCCAGGTGGGGGTGGG- TTTT) similar to that determined as the origin of 334 
replication of the pNSL1 plasmid (48) was identified at the same position upstream from the 335 
rep gene in pVAPN (Fig. 2). The rep-parA module is detected as HGT genetic material in 336 
pNSL1 and is conserved in the circular plasmids pVAPA/B and R. erythropolis pREC1 (in 337 
the latter also identified as HGT). In pVAPN, it is flanked on the right by a phage excisionase 338 
gene (pVAPN_0520) which is conserved in pNSL1 and, interestingly, also in the circular 339 
replicons despite these deriving from a different ancestor (Fig. 2). This lends additional 340 
support to the earlier suggestion that the rep-parA determinant forms part of an 341 
“exchangeable” gene cassette subjected to HGT between different rhodococcal plasmids (24). 342 
This replication/partitioning region appears to serve as an insertion platform for HGT DNA 343 
(24), as suggested by the fact that the VR is either immediately adjacent (pVAPA/B circular 344 
plasmids) or interrupts it (pVAPN, pNSL1 and the larger circular pREC1) (Fig. 2). 345 
Interestingly, in contrast to the circular pVAPA/B plasmids (and pREC1), pVAPN (and 346 
related pNSL1) does not encode the ParB component of the ParAB replicon segregation 347 
system (60). The lack of a parB gene appears to be a hallmark of the smaller (≤400 Kb) 348 
rhodococcal linear extrachromosomal replicons, as exemplified by pREL1 or pBD2 from R. 349 
erythropolis (44), pRHL2 and pRHL3 from R. jostii (37) or pFiD188 from R. fascians (45).  350 
 Plasticity region (VR). The colinearity with pNSL1 is abruptly interrupted at the level 351 
of the traA pseudogene, marking the start of the VR. pVAPN’s VR is interrupted by an island 352 
of homology with ORFs from the right end of pNSL1’s backbone, suggesting it has been 353 
formed by two independent DNA acquisition events (Fig. 2). The left VR section comprises 354 
the pVAPA/B-homologous phage excissionase-rep-copG sequence module (see above) plus 355 
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the vap PAI; the right section encodes rhodococcal/actinobacterial conserved hypothetical 356 
proteins and a number of products with various predicted functions (Fig. 2). The complete left 357 
VR section with the vap PAI is identified as HGT (Fig. 2), suggesting it is a more recent 358 
acquisition.  359 
 vap PAI. pVAPN’s vap PAI genetic structure is similar to that of pVAPA/B (Fig. 5). 360 
It is 15.1 Kb in length and contains 21 ORFs including: (i) a complement of six vap genes 361 
(vapN, -O, -P, -Q pseudogene, -R and -S) encoding polypeptides differing by 20 to 81% in 362 
amino acid sequence identity with pVAPA/B’s Vaps (Table S3); (ii) a vir locus encoding the 363 
two key vap PAI transcriptional regulators, VirR (LysR-type) and VirS (orphan two-364 
component response regulator) (61, 62), a major facilitator superfamily (MFS) transporter 365 
IcgA (63), plus VapP and a conserved protein of unknown function; and (iii) several 366 
additional non-vap genes (Fig. 5). Four of the latter are conserved as functional genes in the 367 
three virulence plasmids, indicating they are core components of the PAI: pVAPN_0700 368 
(pVAPA/B_0420), encoding a hypothetical protein with similarity to a CopG-family 369 
transcriptional regulator (here designated cgf), is the probable first gene of the vap PAI 370 
instead of the downstream lsr2 initially considered (24); pVAPN_0720 (pVAPA/B_0440), 371 
encoding a putative nucleoid-associated protein similar to Lsr2, which in mycobacteria is 372 
involved in a number of virulence-related functions (64-66); pVAPN_0760 373 
(pVAPA/B_0470), encoding an S-adenosylmethionine (SAM)-dependent methyltransferase 374 
with a potential regulatory role via protein, nucleic acid or lipid methylation; and 375 
pVAPN_870 (pVAPA/B_0570), aka vap-coregulated vcgB gene in pVAPA, encoding a 376 
hypothetical protein conserved in pathogenic mycobacteria (67) (Fig. 5). At the right end, the 377 
putative transposon invertase/resolvase invA gene found in pVAPA/B and in the VR of the 378 
related rhodococcal circular pREC1 plasmid (24), is replaced in pVAPN by tniA-like 379 
transposase/integrase and tniQ-like transposase helper protein pseudogenes (Fig 5).  380 
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 vap PAI evolution. A phylogenetic analysis of the vap multigene family was 381 
performed to trace the evolutionary history of the R. equi vap PAI. Maximum Likelihood 382 
(ML) trees grouped the vap genes into several well-supported terminal clades (Figs. 3B, 383 
S4A). vap family members were not clustered by plasmid; instead, vap sequences from 384 
different virulence plasmids were grouped under each of the nodes, suggesting they are allelic 385 
variants of a vertically evolving vap precursor gene. Three of the clades contained vap 386 
sequences from only one or two of the plasmid types, suggesting loss of vap alleles. In 387 
addition, in two cases the clades included more than one vap sequence from the same PAI, 388 
consistent with instances of vap gene duplication (Figs. 3B, S4A). To help pinpointing the 389 
gene duplication and loss events underlying the evolution of the R. equi vap family, the vap 390 
gene tree and a “species” tree of the three PAIs based on their conserved non-vap genes (Fig. 391 
S4B) were compared using NOTUNG phylogenetic reconciliation software (68) (Fig. S5). The 392 
phylogenetic data were then interpreted in combination with a detailed comparative analysis 393 
of the genetic structure of the PAIs (Fig. 5).  394 
 The above analyses inferred that the lowest common ancestor (LCA) of the three vap 395 
PAIs probably comprised seven precursor vap genes, designated 1 to 7. These gave rise to the 396 
contemporary plasmid type-specific allelic variants as schematized in Fig. 3B (see also Figs. 397 
S4A, S5 for additional details). The seven LCA vap gene precursors probably originated by 398 
successive duplication events from a primordial vap gene (Figs. 6, S5), probably acquired by 399 
HGT from another organism. Indeed, while being R. equi-specific among the actinomycetes, 400 
Vap homologs are found in other bacteria from different phyla or even fungi (Fig. S4A).  401 
 The presence in pVAPN, adjacent to the PAI, of an orphan, corrupted copy of traA plus 402 
other sequences from the pVAPA/B housekeeping backbone (phage excisionase-rep-copG 403 
HGT sequence module) (Figs. 2, 5) suggests that the vapN PAI was mobilized to the linear 404 
replicon from an ancestor of the circular pVAPA/B and not vice versa. An identical gene 405 
translocation as that observed for the allelic variants vapG (pVAPA) and vapO (pVAPN) is 406 
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unlikely to have occurred twice independently, indicating that the vapN PAI probably 407 
originated from a direct precursor of pVAPA after diversification from pVAPB. This 408 
interpretation is supported by a phylogenetic analysis performed with the non-vap genes of 409 
the PAI (Fig. S4B). It also accounts for the presence in the vapN PAI of pVAPA’s vapI/E and 410 
vapC/F putative allelic variants vapR and vapS, which are absent in pVAPB (Figs. 5, S5). The 411 
vapA PAI deriving from pVAPN is less plausible because it implies the occurrence, after the 412 
mobilization of the PAI, of a second, independent horizontal transfer/recombination event 413 
conveying the traA-phage excissionase-rep-copG module from pVAPA/B to pVAPN. The 414 
probable evolutionary history of the vap PAI in the three host-adapted R. equi virulence 415 
plasmids is schematized in Fig. 6.  416 
 pVAPN and its vapN gene are essential for intracellular proliferation in 417 
macrophages. To determine the role of pVAPN in virulence, we obtained an isogenic 418 
plasmid-cured derivative of 1571 (1571–) and examined its behavior in in vitro infection 419 
assays in mouse J774A.1 and human THP-1 macrophages. Studies with the equine plasmid 420 
previously showed that VapA is essential for R. equi virulence (26, 27), in contrast to other 421 
pVAPA-encoded Vap products (i.e. VapC, -D, -E, -F (26), -G (23) or -H [A. Hapeshi et al., 422 
unpublished]), which are dispensable or accessory. Since our data above suggest that vapN is 423 
pVAPN’s ortholog/allelic variant of vapA, an isogenic unmarked in-frame vapN deletion 424 
mutant was also constructed and tested. A plasmidless derivative and a vapA deletion mutant 425 
of equine isolate 103S (strains 103S– and 103SΔvapA, respectively) (27) were used as 426 
controls.  427 
  Fig. 7A shows that both 1571– and 1571ΔvapN had lost the ability to proliferate in 428 
J774A.1 and THP-1 cells. The effects were essentially identical to those observed for 103S– 429 
and 103SΔvapA, respectively (Fig. 7B). These results demonstrate that the bovine plasmid 430 
pVAPN is, like the equine pVAPA, necessary for facilitating R. equi parasitization of host 431 
macrophages. They also show that vapN appears to perform an essential function in 432 
 17
pathogenesis, similar to vapA in the equine plasmid (26). Uptake of 1571– and 1571ΔvapN 433 
remained unaffected and the same was observed for 103S– and 103SΔvapA (Fig. S6), 434 
indicating that the effect of the two plasmids and their cognate VapN and VapA products is 435 
specifically related to intracellular survival and/or replication.  436 
 Role of pVAPN and vapN in virulence in vivo. The 1571 strain and its plasmidless 437 
derivative 1571– were also tested in mice using a competitive lung infection model (27). 438 
Immunocompetent BALB/c mice were infected via the intranasal route with a ≈1:1 mix of the 439 
test bacteria and R. equi burdens determined by plate counting over a four-day period, in 440 
which we previously determined R. equi numbers remain stable in the lung (27). The relative 441 
proportions of the two strains were then determined for each time point by PCR and the 442 
corresponding competitive indexes (C.I.) calculated (see Materials & Methods).  443 
  Plasmidless 1571– bacteria were cleared from the lungs at a much faster rate than the 444 
1571 parent strain (Fig. 8A). Except for t = 0, when similar numbers of 1571 and 1571– were 445 
recovered, the C.I. was significantly lower than 1 at all time points (Table 1). By day 3 most 446 
(96.3 %) of the bacteria were plasmid-positive whilst, at day 4, the 1571– strain was not 447 
detected despite total CFU numbers remaining stable in the lungs, indicating that the plasmid-448 
cured bacteria were strongly outcompeted  (Fig. 8A). This pattern mirrored the results 449 
observed when the same experiment was performed with R. equi 103S and its plasmidless 450 
derivative 103S– (27). These data demonstrate that the bovine-type pVAPN plasmid, like the 451 
equine pVAPA, confers to R. equi the ability to survive in vivo in an animal host.  452 
  We next analysed the role of VapN in pVAPN-promoted virulence in mice. Since, 453 
according to the macrophage data, the lack of VapN was likely to cause strong attenuation in 454 
vivo, we compared the competitive ability of 1571ΔvapN against the non-virulent derivative 455 
1571– (27). This approach takes advantage of the greater sensitivity of competitive tests in 456 
assessing small differences in virulence (69, 70) and, to ascertain the relative importance of 457 
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VapN and other pVAPN products in R. equi virulence, is potentially more informative than a 458 
comparison with the fully virulent parent strain. 459 
  While the 1571– strain was readily displaced by the plasmid-positive 1571, sizable 460 
numbers of both ΔvapN and 1571– were recovered at all time points (Fig. 8B). This is similar 461 
to the behaviour of 103SΔvapA and 103S– using the same experimental conditions (27), 462 
demonstrating that loss of VapN is sufficient to cause a reduction in virulence comparable to 463 
that in the absence of its coding pVAPN plasmid. Nevertheless, the C.I. data showed partial 464 
outcompetition of plasmid-cured 1571– by ΔvapN, particularly during the two first time points 465 
(Table 1). No such differences were observed in our previous 103SΔvapA vs 103S– 466 
comparison (27). This indicates that pVAPN products other than VapN are also potentially 467 
important for R. equi survival in mice, and that some differences might exist in the 468 
contribution to virulence of VapN and VapA in their respective backgrounds.  469 
 Collectively, our data support the notion that VapN and VapA are allelic variants of a 470 
same vap gene with a key role in R. equi virulence, presumably because essential for 471 
supporting rhodococcal intramacrophage proliferation.  472 
 pVAPN transferability by mating. We finally tested whether pVAPN is transferable 473 
by mating, as predicted from the sequence data. Experiments were carried out with the 1571 474 
strain as donor and a rifampicin-resistant (RmpR) plasmidless 103S– (103S–RmpR) as recipient. 475 
The two strains belong to different R. equi chromosomal genogroups (E. Anastasi et al., 476 
manuscript in preparation). As a control, conjugation tests with pVAPA from 103S, for which 477 
transfer frequencies in the range of 10–2 have been previously reported (39), were performed 478 
using the same recipient. Transconjugants were determined by screening a total of 900 479 
random RmpR (100 μg/ml) colonies using suitable recipient- and virulence plasmid-specific 480 
PCR markers. Transfer of pVAPA to 103S– was observed at a frequency of 1.25×10–2 but 481 
could not be detected for pVAPN. We reasoned that the linear pVAPN could be transferable 482 
at a lower frequency, unworkable for the PCR-based screening method used. To circumvent 483 
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this, a transconjugant selection strategy was devised based on the ability of the virulence 484 
plasmid to promote R. equi survival in vivo. BALB/c mice were infected intravenously (i.v.) 485 
with ≈4×108 CFU of a mating mix of 1571 and 103S–RmpR, followed by plating of spleen and 486 
liver homogenates onto rifampicin plates at days 0, 3, and 5 after infection. Based on previous 487 
i.v. infection data in mice (27), this time course was expected to lead to progressive 488 
elimination of plasmid-negative R. equi and concomitant increase of the plasmid-positive 489 
population. The recovered pVAPN-positive/RmpR bacteria were confirmed as transconjugants 490 
by PCR using suitable strain-specific gene markers and determination of strain-specific DNA 491 
sequences (see Table S1 and Materials & Methods). 492 
 Fig. 9A demonstrates a steady enrichment of pVAPN-positive transconjugants, from 493 
0.5% at day 0 to 34.5% at day 3 and 80.3% at day 5. These data show that pVAPN is 494 
transferable between different R. equi strains. The positive selection in mice of 103S– pVAPN 495 
transconjugants indicates that the bovine plasmid promotes R. equi virulence irrespective of 496 
the strain hosting it. Experiments in J774A.1 cells demonstrated that acquisition of pVAPN is 497 
sufficient to confer to R. equi the capacity for intracellular survival in macrophages (Fig. 9B).   498 
 Conclusions. Our previous work established that the equine-type pVAPA and 499 
porcine-type pVAPB plasmids are the same circular replicon in which the HGT-acquired vap 500 
PAI evolved divergently, presumably by host-driven selection (24). Our new data show that 501 
the bovine pVAPN plasmid was originated by horizontal mobilization of the vap PAI to a 502 
linear invertron-like replicon. The pVAPN vap locus, like pVAPA/B’s, is an HGT island and 503 
is flanked by DNA mobility genes, consistent with a recent lateral acquisition, probably 504 
involving a phage or a transposon.  505 
 Both the circular pVAPA/B (24) and linear pVAPN backbones share a common origin 506 
with other extrachromosomal conjugative replicons found in environmental rhodococci. 507 
Rhodococcal plasmids play a key role in facilitating adaptation to different habitats and 508 
environments via plasticity regions rich in HGT material. In the environmental biodegradative 509 
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rhodococci, these plasticity regions typically encode catabolic, detoxification or secondary 510 
metabolic determinants while in the pathogenic species (R. equi and R. fascians) they are 511 
virulence related (1, 46, 71). In the phytopathogen R. fascians, virulence is conferred by a 512 
linear conjugative plasmid (45) without obvious similarity to pVAPN, illustrating that 513 
multiple extrachromosomal elements serve as platforms for the expression and dynamic 514 
exchange of niche-adaptive traits in the genus Rhodococcus.  515 
 Our findings suggest the following hypothetical scenario for the evolution of virulence 516 
in R. equi (Fig. 6). First, acquisition of an ancestral vap PAI by a circular conjugative plasmid 517 
endowed a “pre-R. equi” obligate saprotroph with intracellular survival capability in 518 
macrophages, promoting its conversion into a facultative parasite. During co-evolution with 519 
animal hosts, porcine- and equine-specific tropism evolved as a secondary trait of the PAI in 520 
the circular plasmid (Fig. 6B), involving gene duplication and sequence diversification within 521 
the vap multigene family (Fig. 6A). Finally, acquisition of the vap PAI by a linear plasmid, 522 
presumably from a direct precursor of the equine pVAPA (Fig. 6B), gave rise to the bovine-523 
adapted pVAPN in which another set of specific vap genes evolved (Fig. 6A).  524 
 Our analyses with pVAPN confirm the notion that the primary function of the R. equi 525 
virulence plasmids is to support intracellular proliferation in macrophages. This primordial 526 
function is clearly dissociable from host tropism, since epidemiological or experimental 527 
evidence indicates that R. equi plasmids promote virulence in accidental (non-adapted) animal 528 
hosts, such as humans or mice, regardless of their species-specific type. Our data indicate that 529 
a specific vap gene, which was present in the nearest common ancestor of the contemporary 530 
PAIs and evolved into the allelic variants vapA in pVAPA and vapN in pVAPN (and possibly 531 
vapB in the porcine pVAPB), is critical for intracellular survival in macrophages. 532 
 Why bovine host tropism evolved in a linear replicon and not by further host-driven 533 
diversification of the PAI in the circular pVAP replicon remains unclear. Since pVAPA and 534 
pVAPB share a virtually identical circular backbone, equine- and porcine-specific infectivity 535 
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most likely resides in their divergent vap PAI. Whether determinants outside the vap PAI in 536 
the unrelated pVAPN backbone contribute adaptive features which optimize the interaction of 537 
R. equi with the bovine host requires further investigation.  538 
 The findings in this study establish R. equi as a novel paradigm of multihost-adapted 539 
pathogen. The pVAPN plasmid here reported, together with the previously characterized 540 
equine- and porcine-associated plasmids, provide a unique model system to gain a better 541 
understanding of the bacterial mechanisms of intramacrophage survival and host tropism. 542 
 543 
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Table 1. Competitive indexes (C.I.) of Fig. 8 experiments. Mean values ±SEM. A C.I. equal to 786 
1 is the theoretical value of two strains with the same competitive ability. Data significance was 787 
calculated by comparing the experimental C.I. value at each time point against the theoretical 788 
value 1 (one sample Student’s t test). 789 
 790 
 791 
 
Competing 
strains 
 C.I.  (P value) 
 day 0  day 1  day 2  day 3  day 4 
1571− / 1571   
1.54±0.20 
(.0763)  
0.42±0.13 
(.0225)  
0.40±0.12 
(.0407)  
0.06±0.06 
(.0051)  
0.0 
(.0001) 
∆vapN / 1571–   
0.88±0.13 
(.4761)  
2.24±0.16 
(.0049)  
3.36±0.41 
(.0107)  
1.47±0.09  
(.0363)  
2.68±0.64 
(.1197) 
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FIGURE LEGENDS  792 
 793 
FIG 1. Detection of pVAPN by PFGE. (A) Genomic DNA of bovine isolate 1571 and equine 794 
isolate 103S; three and two independent lysates per strain are shown. Relevant positions of 795 
the lambda PFGE marker (New England Biolabs) are indicated. pVAPN is observable as a 796 
distinct PFGE band of ≈100 Kb in the bovine isolate. (B) Southern blot analysis of bovine 797 
isolates PAM nos. 1571, 1533 and 1554 (strain 103S used as negative control). Left, relevant 798 
sections of PFGE gel; right, membrane hybridized with a pVAPN-specific DNA probe (600 799 
bp fragment encompassing the 3’ region of vapN and 5’ region of vapQ). Arrow indicates the 800 
pVAPN band.  801 
 802 
FIG 2. Plasmid genome alignments. Linear pVAPN, circular pVAPA and pVAPB, and 803 
respective closest homologs from non-pathogenic rhodococcal species (pNSL1 from 804 
Rhodococcus sp. NS1 (48) and pREC1 from R. erythropolis (44)). Built with EASYFIG 805 
(http://easyfig.sourceforge.net/). The circular plasmids (pVAPA, pVAPB, pREC1) were 806 
linearized starting from the first conserved gene of the housekeeping backbone. Regions with 807 
significant similarity between plasmids are connected by gray stripes (tblastx, 0.1 e-value 808 
threshold); grayscale indicates percent similarity. ORFs are color coded according to 809 
predicted function: hypothetical protein (gray), conjugation or DNA 810 
replication/recombination/metabolism (red), DNA mobility genes (magenta), transcriptional 811 
regulators (blue), secreted proteins (dark green), membrane proteins (pale green), metabolic 812 
functions (yellow), vap family gene (black); pseudogenes (brown). Other features indicated: 813 
green and pale red bars below the genes, conjugation and replication/partitioning functional 814 
modules, respectively; dotted underline, HGT regions identified by ALIEN HUNTER (52); 815 
triangle, putative origin of replication. Relevant gene products are labelled with abbreviations.  816 
 817 
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FIG 3. Maximum Likelihood (ML) trees of (A) Rhodococcus plasmid backbones and (B) R. 818 
equi vap multigene family. HKY+G evolutionary model. (A) Based on concatenated 819 
alignment of orthologs from a selection of rhodococcal extrachromosomal replicons (total 820 
7,802 nucleotides); genes used indicated by dots in Fig. 2. Values >50 for 100 bootstrap 821 
replicates are indicated. Symbols: triangles, linear plasmids; circles, circular plasmids. (B) 822 
vap family members derived from each of the predicted seven precursor vap genes in the 823 
lowest common ancestor (LCA) of the extant pVAPA, pVAPB and pVAPN PAIs are 824 
encircled within gray balloons.  825 
  826 
FIG 4. pVAPN telomeric sequences. (A) ClustalΩ alignment of the left- and right-end 200 827 
terminal nucleotides. Identical nucleotides are shaded (dark and light blue, purines and 828 
pyrimidines, respectively). Inverted repeats are indicated above the sequence. In red, four 829 
conserved palindromic sequences with the central motif GCTNCGC identified in the binding 830 
site of telomere-associated proteins involved in Streptomyces linear plasmid replication (73). 831 
Several of the GCTNCGC palindromic sequences are normally present in the telomeres of 832 
rhodococcal linear plasmids (43-45) (Fig. S2). (B) Secondary structures potentially formed by 833 
the palindromic sequences in pVAPN telomeres, as numbered in (A). Determined with 834 
MFOLD. Free energy: left, ΔG = -33.84 kcal/mol; right, ΔG = -37.95 kcal/mol. 835 
 836 
FIG 5. Genetic structure of the vap PAIs from pVAPN (15.1 Kb), pVAPA (21.5 Kb) and 837 
pVAPB (15.9 Kb). Genes are color-coded according to functional category: vap family 838 
(black), DNA conjugation/partitioning (red), DNA mobility/recombination (magenta), 839 
transcriptional regulators (blue), other regulators (cyan), membrane proteins (green), 840 
metabolic reactions (yellow). Orthologs are in the same color shade and linked by gray bands. 841 
ORFs encoding hypothetical proteins are represented in light blue-gray, in white if outside the 842 
PAI. White arrowheads point to the first and last genes of the consensus PAI. The traA 843 
 30
pseudogene/phage excissionase-rep-copG HGT cluster from the pVAPA backbone is boxed. 844 
The figure also schematizes the probable evolutionary relationships of the vap multigene 845 
family as inferred from the phylogenetic analyses (Figs. 3B, S4, S5) and PAI genetic 846 
structure; the model minimizes the number of vap gene loss events. Solid lines/arrows 847 
connect vap genes belonging to the same monophyletic group (thus likely representing allelic 848 
variants of a nearest common vap gene ancestor). Curved lines/arrows indicate vap gene 849 
duplications within a PAI. Crosses denote vap genes lost, asterisks indicate pseudogenes. Two 850 
alternative evolutionary paths are shown for vapA-B-K1/2-N (see legend to Fig. S5 for 851 
additional details). The black dots indicate the non-vap genes used for the MLSA analysis in 852 
Fig. S4B.  853 
 854 
FIG 6. Hypothetical reconstruction of vap PAI evolution. (A) Model of vap multigene family 855 
evolution. Lines indicate the evolutionary path of the vap genes between ancestral PAI 856 
lineages L0 to L0’’, nearest common ancestor (LCA) and extant PAIs. Pre-pVAPA designates 857 
the hypothetical direct precursor of the current pVAPA PAI. Gene birth-duplication events 858 
are indicated by red squares, loss events by crosses, pseudogenes by asterisks and white 859 
rimming. (B) Fate of vap PAI in R. equi virulence plasmid evolution. (a) Acquisition by 860 
rhodococcal circular replicon of vap PAI ancestor conferring ability to colonize macrophages; 861 
(b) Mobilization of vap PAI from pre-pVAPA plasmid to rhodococcal linear replicon; (c) 862 
evolution of species-specificity. 863 
 864 
FIG 7. Intracellular proliferation experiments in murine (J774A.1) and human (THP-1) 865 
macrophages. Data expressed as normalized Intracellular Growth Coefficient (IGC; see 866 
Materials & Methods). Means of three duplicate experiments ±SEM. Statistical significance 867 
analyzed by 2-way ANOVA; P values of Šidák post-hoc multiple comparisons at each time 868 
point are shown if ≤0.05. (A) Plasmidless derivative and in-frame ΔvapN mutant of bovine 869 
 31
isolate 1571. Two-way ANOVA P values: J774A.1 = 0.0007, THP-1 = 0.0160. (B) Plasmidless 870 
derivative and in-frame ΔvapA mutant of equine isolate 103S. Two-way ANOVA P values: 871 
J774A.1 = 0.0112, THP-1 < 0.0001.  872 
 873 
FIG 8. Competitive virulence assay in mouse lung. BALB/c mice (n = 4 per time point) were 874 
infected intranasally with a ≈1:1 mixture of the test bacteria and the competing populations 875 
monitored 60 min after infection (t = 0) and then daily on four consecutive days. Bar height 876 
denotes total lung CFU and the light and dark grey areas within bars indicates the proportion 877 
of the competing bacteria. Corresponding competitive index (C.I.) are shown in Table 1. (A) 878 
Competition between wild-type bovine isolate 1571 and isogenic plasmidless derivative 1571–879 
; infection dose: 3.7×107 CFU/mouse (2.3×107 and 1.4×107, respectively). (B) Competition 880 
between the avirulent 1571– strain and in-frame 1571ΔvapN deletion mutant. Infection dose: 881 
7.8×107 CFU/mouse (3.2×107 and 4.6×107, respectively). 882 
 883 
FIG 9. Transfer of pVAPN by mating confers virulence to a plasmid-negative R. equi 884 
recipient strain. (A) In vivo selection of pVAPN transconjugants in mice. Note the progressive 885 
enrichment of the recipient 103S–RmpR strain upon acquisition of the pVAPN plasmid. t = 0, 886 
60 min after infection. (B) Intracellular proliferation in J774A.1 macrophages. Acquisition of 887 
pVAPN (and the control pVAPA) plasmid promotes intracellular proliferation to the recipient 888 
103S–RmpR strain. Data expressed as normalized Intracellular Growth Coefficient (IGC; see 889 
Materials & Methods). Mean of three duplicate experiments ±SEM; P values (2-way ANOVA, 890 
Šidák post-hoc multiple comparison) are indicated.  891 
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